According to current data from the Centers for Disease Control, Black women in the United States are 40% more likely to die from breast cancer than their white counterparts. Identification of individuals who are at higher risk of developing breast cancer, such as individuals who carry BRCA1 or BRCA2 mutations can help to reduce this disparity. However multiple studies have demonstrated that rates of BRCA1 and BRCA2 testing in the United States are substantially lower in Black women than white women.